Navigation Links
Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine

ents with menstrual migraine and predictable menses, I am intrigued by the potential for a short-term prevention treatment to prevent or minimize MM symptoms without continuously exposing patients to a drug," said Stephen Silberstein, M.D., professor of neurology at the Jefferson Medical College of Thomas Jefferson University, director of the Jefferson Headache Center and lead investigator of the initial efficacy study of FROVA for the short-term prevention of menstrual migraine.

Study Results

In the trial, the MM status of study participants was confirmed during a placebo-controlled, single-blind, run-in phase. Women were randomized in the double-blind study to receive FROVA 2.5 mg once a day, FROVA 2.5 mg twice a day, or placebo (ratio 3:2:3).

FROVA once or twice daily significantly improved the number of headache-free perimenstrual periods (PMPs) compared to women who received placebo. FROVA also significantly reduced the incidence of severe migraines and therefore tended to improve the ratio of severe to mild headache compared to women who received placebo. Efficacy data were collected from 410 women in North America and Europe, 85 percent of whom participated in the study over three PMPs. Efficacy data were collected from 410 women in North America and Europe, 85 percent of whom participated in the study over three PMPs.

The study's primary endpoint was the number of completely headache-free PMPs. FROVA therapy significantly improved the number of headache-free PMPs per patient (0.92 [twice daily], p < 0.0001; 0.69 [once daily], p=0.009) versus 0.42 (placebo). The incidence of severe headache was significantly less with FROVA once daily (44 percent; p=0.007) and twice daily (40 percent; p=0.0003) compared with placebo (58 percent), lowering the ratio of severe to mild migraine from 11:1 with placebo to 4:1 [once daily] and 2:1 [twice daily] with FROVA.

Reductions in migraine symptoms were significant for nausea (twice daily on
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:7/21/2014)... NEW YORK , July 21, 2014  EHE ... physical exams with a nationwide physician network, today announced ... Las Vegas, NV has been named ... in the Las Vegas region ... to help proactively maintain their health. ...
(Date:7/21/2014)... New York , July 21, 2014 ... report published by Transparency Market Research "E-Clinical Solution Software ... Forecast, 2014 - 2020," the global microfluidic device market ... is expected to grow at a CAGR of 13.8% ... of USD 6,515.3 million in 2020. Browse ...
(Date:7/21/2014)... LAS VEGAS , July 21, 2014 By ... Division will conduct an online sale of ophthalmic and optical ... Las Vegas -based eyewear specialists American Optical Services LLC. ... and will close in rapid succession, live auction style, ... the various assets being offered will be held July 25 ...
Breaking Medicine Technology:EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5Auction Set For Assets Of National Optical Services Company 2
(Date:7/22/2014)... 22, 2014 Dr. Allen Kamrava, colorectal ... launch of a new website dedicated to the diagnosis ... be found at DrKamrava.com . , “With this ... a knowledgeable and trustworthy source for various colorectal ... hemorrhoids, fissures, gallstones, colon cancer, hernias, or more, patients ...
(Date:7/22/2014)... Angeles, CA (PRWEB) July 22, 2014 ... online marketing training course that takes a comprehensive, step-by-step ... scale an online marketing venture has just been released ... Hendricks. , “In the internet marketing world if you’re ... Hendricks. “And a lot of people simply give up ...
(Date:7/22/2014)... 2014 Eating certain foods can not only ... according to two of the world’s top cosmetic dentists. ... of the Anacapa Dental Art Institute in Oxnard and Woodland ... of one’s teeth. They are specially trained to replace missing ... not seeing a dentist regularly, and about two-thirds of the ...
(Date:7/22/2014)... Kirby Lester, LLC, the leading pharmacy automation ... functionality to perform a trackable double-count for any prescription ... double-count of controlled medications is required, the KL1Plus allows ... a second count of any tablet or capsule order. ... second count up to 10 years. This function is ...
(Date:7/22/2014)... 22, 2014 Industry-leading health business information ... release of Specialty Pharmacy Trends and Strategies: 2014 ... provides a comprehensive overview of the current state of ... strategies and tactics for:, , Specialty ... utilization concerns — including details of coinsurance levels by ...
Breaking Medicine News(10 mins):Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 2Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 3Health News:Info Cash 2.0: Review Of Chris Carpenter’s Online Marketing Training Released 2Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 2Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 3Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 4Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 5Health News:Kirby Lester KL1Plus Pharmacy Automation Perfect for Double-Counting & Tracking Prescriptions from Any Pharmacy Robot 2Health News:Latest Edition of Annual Book Provides Comprehensive Overview of the Specialty Pharmacy Arena 2
... declined dramatically after the establishment of North America,s first ... the findings of a groundbreaking new study published in ... first peer-reviewed study to assess the impact of supervised ... reduction in overdose deaths in the immediate vicinity of ...
... , THURSDAY, April 21 (HealthDay News) -- For men ... don,t measure up -- success can be found in ... by Italian researchers contends. Concerned that patients were ... the penis, the researchers examined the medical literature to ...
... obese adolescents are no more likely to be depressed than ... online in the Journal of Adolescent Health , did ... psychological effects of obesity. This three-year study performed ... Policy at MassGeneral Hospital for Children (MGHfC) and the Department ...
... 21 (HealthDay News) -- Long-term use of topical corticosteroids to ... cause any major negative side effects, according to a new ... corticosteroid creams or lotions applied to the skin and this ... explained. The most common fear among parents is that these ...
... Dotinga HealthDay Reporter , THURSDAY, April 21 (HealthDay ... exposure to a class of pesticides widely used on food ... is especially noticeable in kids from a California farming region ... pesticides through their use on local crops. ...
... effects of mindfulness meditation on pain and working memory ... crucial brain wave called the alpha rhythm. This rhythm ... information, which suggests that a key value of meditation ... world. Researchers from Massachusetts General Hospital (MGH), Harvard Medical ...
Cached Medicine News:Health News:Deaths from drug overdose decline 35 percent after the opening of supervised injection site 2Health News:When Size Matters, Men Can Turn to Penile Extenders: Study 2Health News:When Size Matters, Men Can Turn to Penile Extenders: Study 3Health News:Severe obesity not seen to increase risk of depression in teens 2Health News:Corticosteroid Creams Safe for Kids With Eczema: Study 2Health News:Pesticide Exposure in Pregnancy Linked to Lower IQ in Kids 2Health News:Pesticide Exposure in Pregnancy Linked to Lower IQ in Kids 3Health News:Meditation may help the brain 'turn down the volume' on distractions 2Health News:Meditation may help the brain 'turn down the volume' on distractions 3